<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 2; Issue 3</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>(May-Jun, 2021)</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>Importance of Alpha Lipoic Acid (ALA): Antidiabetic and Antioxidant Effects</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>9</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Anna</FirstName>
          <LastName>Votano</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Alessia Bonofiglio</FirstName>
          <LastName/>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Federica Catalano</FirstName>
          <LastName/>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Claudia</FirstName>
          <LastName>Paone</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Within our organism, during the numerous metabolic reactions, free radicals (or ROS) are formed, unstable molecules that contain one or more unseated electrons and are responsible for oxidative stress. The organism must cope with and eliminate these free radicals that can create indiscriminate damage on biological macromolecules. To counteract their action and prevent cellular oxidation, the presence of molecules defined as antioxidants is fundamental. Some studies have seen that oxidative stress, caused by the presence of fress radicals, is related to the onset of cardiovascular disease, diabetes, tumors and other chronic diseases.&#13;
&#13;
Alpha lipoic acid (ALA) is an acid know for its positive effects on health, in particular its antidiabetic and antioxidant effects, and its effects on weight loss. Given its properties, in this study we want to explain in detail the mechanisms that determine these effects, also based on what is found in the literature. Objective: Analyse the importance of alpha lipoic acid and its antidiabetic and antioxidant effects.&#13;
&#13;
Design: We have based the study in a bibliographic review.&#13;
&#13;
Result: The antioxidant effect is due to its ability to neutralize free radicals and oxygen reactive species (ROS) and the ability to enhance the action of other endogenous antioxidants, such as vitamin E and vitamin C. The antidiabetic effect is to improve the effectiveness of insulin and the transport of glucose into cells, thus leading to a reduction in insulin resistance.&#13;
&#13;
Conclusions: With this study we have demonstrated in detail the main mechanisms by which ALA acts and determines its antioxidant and antidiabetic effects. Our body is able to defend itself against ROS thanks to the presence of natual antioxidant substances, but sometimes these are not enough, so it is necessary to take supplements. It should be remembered that ALA is not a medicine and has no healing properties but its integration can be useful for the well-being of the organism.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Alpha Lipoic Acid,Diabetes,Antioxidant Effects,Antidiabetic Effects</Keywords>
      <URLs>
        <Abstract>https://jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=9608&amp;title=Importance of Alpha Lipoic Acid (ALA): Antidiabetic and Antioxidant Effects</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Agathos E, Tentolouris A, Eleftheriadou I, Katsaouni P, Nemtzas I, Petrou A, Papanikolaou C, Tentolouris N. Effect of and;alpha;-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy. J Int Med Res 2018; 46: 1779-1790.&#13;
&#13;
Amara F, Hafez S, Orabi A, El Etriby A, Rahim AA, Zakaria E, Koura F, Talaat FM, Gawish H, Attia I, Aziz MF. Review of Diabetic Polyneuropathy: Pathogenesis, Diagnosis and Management According to the Consensus of Egyptian Experts. Curr Diabetes Rev 2019; 15: 340-345.&#13;
&#13;
Andreea Rotaru. The Neuroprotective role of alpha thioctic acid and vitamin B complex in diabetic neuropathy – an experimental study. Curr Health Sci J 2020; 46: 150-155.&#13;
&#13;
Anna Goraca. Lipoic acid-biological activity and therapeutic potential. Pharmacological Reports 2011; 63: 849-858.&#13;
&#13;
Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997; 29: 315-331.&#13;
&#13;
Brufani M and Figliola R. (R)-and;alpha;-lipoic acid oral liquid formulation: pharmacokinetic parameters and therapeutic efficacy. Acta Biomed 2014; 85: 108-115.&#13;
&#13;
Carrier B, Wen S, Zigouras S, Browne RW, Li Z, Patel MS, Williamson DL, Rideout TC. Alpha-lipoic acid reduces LDL-particle number and PCSK9 concentrations in high-fat fed obese zucker rats. PLoS One 2014; 9: e90863.&#13;
&#13;
Ciudin A, Simand;oacute;-Servat O, Hernand;aacute;ndez C, Arcos G, Diego S, Sanabria and;Aacute;, Sotolongo and;Oacute;, Hernand;aacute;ndez I, Boada M, Simand;oacute; R. Retinal Microperimentry: A New Tool for Identifyng Patients with Tyoe 2 Diabetes at Risk for Developing Alzheimer Disease. Diabetes 2017; 66: 3098-3104.&#13;
&#13;
Derosa G, D’Angelo A, Romano D, Maffioli P. A Clinical Trial about a food supplement containing and;alpha;-Lipoic Acid on Oxidative Stress markers in Type 2 Diabetic Patients. Int J Mol Sci 2016; 17: 1802.&#13;
&#13;
El Barky AR, Hussein SA, Mohamed TM. The potent antioxidant alpha lipoic acid. J Plant Chem and Ecophysiology 2017; 2: id1016.&#13;
&#13;
Ergul Belge Kurutas. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J 2016; 15: 71.&#13;
&#13;
Fogacci F, Rizzo M, Krogager C, Kennedy C, Georges CM, KneĹževi? T, Liberopoulos E, Valland;eacute;e A, Pand;eacute;rez-Martand;iacute;nez P, Wenstedt EF, and;Scaron;atrauskien? A. Safety evaluation of and;alpha;-lipoic acid supplementation: a systematic review and meta-analysis of randomized placebo-controlled clinical studies. Antioxidants (Basel) 2020; 9: 1011.&#13;
&#13;
Ghibu S, Richard C, Vergely C, Zeller M, Cottin Y, Rochette L. Antioxidant properties of an endogenous thiol: alpha-lipoic acid, useful in the prevention of cardiovascular disease. J Cardiovascular Pharmacol 2009; 54: 391-398&#13;
&#13;
Gomes MB and Negrato CA. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chornic diseases. Diabetol Metab Syndr 2014; 6: 1-8.&#13;
&#13;
Gorca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, Skibska B. Lipoic acid - biologic–l activity and therapeutic potential. Pharmacol Rep 2011; 63: 849-858.&#13;
&#13;
Halliwell B and Gutteridge JM. The antioxidants of human extracellular fluids. Arch. Biochem. Biophys 1990; 208: 1-8.&#13;
&#13;
Kasote DM, Katyare SS, Hegde MV, Bae H. Significance of antioxidant potential of plants and its relevance to therapeutic applications. Int J Biol Sci 2015; 11: 982-991.&#13;
&#13;
Koh EH, Lee WJ, Lee SA, Kim EH, Cho EH, Jeong E, Kim DW, Kim MS, Park JY, Park KG, Lee HJ. Effects of alpha-lipoic acid on body weight in obese subjects. Am J Med 2011; 124: 85.e1-8.&#13;
&#13;
Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T, Klip A. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 2001; 50: 1464-1471.&#13;
&#13;
Kucukgoncu S, Zhou E, Lucas KB, Tek C. Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials. Obes Rev 2018; 18: 594-601.&#13;
&#13;
Mendoza-Nand;uacute;and;ntilde;ez VM, Garcand;iacute;a-Martand;iacute;nez BI, Rosado-Pand;eacute;rez J, Santiago-Osorio E, Pedraza-Chaverri J, Hernand;aacute;ndez-Abad VJ. The effect of 600 mg aplpha-lipoic acid supplementation on oxidative stress, inflammation, and RAGE in older adults with type 2 diabetes mellitus. Oxid Med Cell Longev 2019; 2019: 3276958.&#13;
&#13;
Mijnhout GS, Kollen BJ, Alkhalaf A, Kleefstra N, Bilo HJ. Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials. Int J Endocrinol 2012; 2012: 456279&#13;
&#13;
Mrakic-Sposta S, Vezzoli A, Maderna L, Gregorini F, Montorsi M, Moretti S, Greco F, Cova E, Gussoni M. R (+) – Thioctic Acid Effects on Oxidative Stress and Peripheral neuropathy in type II diabetic patients: preliminary results by elctron paramagnetic resonance and electroneurography. Oxid Med Cell Longev 2018; 2018: 1767265.&#13;
&#13;
Neurodiab. Scientific Program and Abstract Book. Rome, 2018.&#13;
&#13;
Oluwafemi OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol 2019; 11: 45-63.&#13;
&#13;
Papachristoforou E, Lambadiari V, Maratou E, Makrilakis K. Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications. J Diabetes Res 2020; 2020: 7489795.&#13;
&#13;
Perez-Matos MC, Morales-Alvarez MC, Mendivil CO. Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy? J Diabetes Res 2017; 2017: 6943851.&#13;
&#13;
Rossant J and Howard L. Signaling pathways in vascular development. Ann Rev Cell Dev Biol 2002; 18: 541.&#13;
&#13;
Salehi B, Berkay Y?lmaz Y, Antika G, Boyunegmez Tumer T, Fawzi Mahomoodally M, Lobine D, Akram M, Riaz M, Capanoglu E, Sharopov F, Martins N. Insight on the Use of and;alpha;-Lipoic Acid for Therapeutic Purposes. Biomolecules 2019; 9: 356.&#13;
&#13;
Salehi B, Martorell M, Arbiser JL, Sureda A, Martins N, Maurya PK, Sharifi-Rad M, Kumar P, Sharifi-Rad J. Antioxidants: positive or negative actors? Biomolecules 2018; 8: 124.&#13;
&#13;
Schmidt HH, Stocker R, Vollbracht C, Paulsen G, Riley D, Daiber A, Cuadrado A. Antioxidants in translation medicine. Antioxid Redox Signal 2015; 23: 1130-1143.&#13;
&#13;
Solmonson A and DeBerardinis RJ. Lipoic acid metabolism and mitochondrial redox regulation. J Biol chem 2018; 293: 7522-7530.&#13;
&#13;
Su H, Ji L, Xing W, Zhang W, Zhou H, Qian X, Wang X, Gao F, Sun X, Zhang H. Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia/reperfusion injury: role of thioredoxin-interacting protein. J Cell Mol Med 2013; 17: 181-191.&#13;
&#13;
Tutelyan VA, Makhova AA, Pogozheva AV, Shikh EV, Elizarova EV, Khotimchenko SA. Lipoic acid: physiological role and prospects for clinical application. Vopr Pitan 2019; 88: 6-11.&#13;
&#13;
Uchida R, Okamoto H, Ikuta N, Terao K, Hirota T. Enantioselective Pharmacokinetics of and;alpha;-Lipoic acid in rats. Int J Mol Sci 2015; 16: 22781-22784.&#13;
&#13;
Van Houtte PM and Mombouli JV. Vacular endothelium: vasoactive mediators. Progress Cardiovascular Diseases 1996; 39: 229.&#13;
&#13;
Ziegler D. Efficacy and safety of antioxidant treatment with and;alpha;-lipoic acid over 4 years in diabetic polyneuropathy. Diabetes Care 2011; 34: 2054-2060.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>